Aptevo Therapeutics Inc Cash Flow Quality Index
Aptevo Therapeutics Inc cash flow quality index. Aptevo Therapeutics Inc (APVO) has a Cash Flow Quality Index of 1.65x as of March 2023. Operating cash flow of $4.57 Million exceeds net income of $2.77 Million, indicating high earnings quality where cash backs reported profits. See Aptevo Therapeutics Inc (APVO) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Aptevo Therapeutics Inc (2017–2022)
Cash flow quality index of Aptevo Therapeutics Inc from 2017 to 2022. Historical Cash Flow Quality Index for Aptevo Therapeutics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Aptevo Therapeutics Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Aptevo Therapeutics Inc Cash Flow Quality Index by Year (2017–2022)
Aptevo Therapeutics Inc cash flow quality index by year from 2017 to 2022. Year-by-year earnings quality comparison for Aptevo Therapeutics Inc. For the full cash flow conversion analysis, see APVO cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -2.62x | $-21.02 Million | $8.03 Million | ▲ +56.1% |
| 2017 | -5.96x | $-41.57 Million | $6.97 Million | — |